Management of refractory inflammatory bowel disease

Keyphrases

• Refractory Inflammatory Bowel Disease 100%
• Inflammatory Bowel Disease 66%
• Acute Severe Ulcerative Colitis 66%
• Treatment Options 33%
• Infliximab 33%
• Collaborative Care 33%
• Remission 33%
• Treatment Response 33%
• Knowledge Gaps 33%
• Surgical Approach 33%
• Cyclosporine 33%
• Salvage Therapy 33%
• Dose Combination 33%
• Treatment Failure 33%
• Dietary Approaches 33%
• Therapy Interventions 33%
• Dietary Intervention 33%
• Personalized Therapy 33%
• Surgical Options 33%
• Non-response 33%
• Mesenchymal Stem Cell Therapy 33%
• Medical Surgery 33%
• Therapy Options 33%
• Aggressive Phenotype 33%
• Hyperbaric Oxygen 33%
• Medical Approach 33%
• Challenging Patients 33%
• Tofacitinib 33%

Medicine and Dentistry

• Inflammatory Bowel Disease 100%
• Biological Product 75%
• Ulcerative Colitis 50%
• Treatment Response 25%
• Prospective Study 25%
• Personalized Medicine 25%
• Cyclosporine 25%
• Patient with Inflammatory Bowel Disease 25%
• Salvage Therapy 25%
• Hyperbaric Medicine 25%
• Diet Therapy 25%
• Mesenchymal Stem Cell Transplantation 25%
• Infliximab 25%
• Tofacitinib 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Bowel Disease 100%
• Biological Product 60%
• Ulcerative Colitis 40%
• Infliximab 20%
• Prospective Study 20%
• Remission 20%
• Ciclosporin 20%
• Tofacitinib 20%